First Trust SMID Growth Strength ETF (FSGS)

The First Trust SMID Growth Strength ETF (FSGS) sits between two competing instincts in small and mid-cap investing. On one side is the desire to capture growth — the fastest-expanding companies, often the ones that will eventually become large-cap successes. On the other side is the prudent investor’s need for quality, which typically means avoiding the most capital-intensive or debt-heavy businesses. FSGS attempts to thread this needle by selecting companies from the small and mid-cap universe that exhibit both meaningful growth in revenue or earnings alongside the financial discipline to support that growth without reckless leverage. The result is a fund that leans toward faster-growing businesses than its more conservative peer, the SMID Capital Strength fund, but screens out the most speculative operators.

The difference between growth and value investing, and the tension between the two, becomes especially acute in the small and mid-cap space. Large companies are mature, stable, and easy to analyze. A small company, by contrast, may be at an inflection point: a newly public software business, a manufacturing company that just broke through to profitability, a healthcare services provider ramping revenue for the first time. The question investors face is whether that growth is real and sustainable, or whether it is driven by unsustainable unit economics and will collapse when the company hits a ceiling. FSGS attempts to answer this question by combining growth visibility with financial caution.

The fund uses a systematic screening process to identify companies in the small and mid-cap space whose earnings or revenue are expanding at above-average rates, but which also demonstrate reasonable capital discipline. This typically excludes cash-burning biotech firms in early-stage development, highly leveraged roll-up companies that are growing through acquisition rather than organic expansion, and unprofitable technology startups. Instead, the fund tends to capture profitable or near-profitable growth businesses — companies with repeatable revenue models, positive or modest-positive cash flow, and the financial flexibility to continue investing in growth without threatening their balance sheets.

During bull markets and periods of strong economic growth, the appeal of this positioning becomes clear. Investors hungry for returns will often move up the risk spectrum from mega-cap stalwarts toward smaller, faster-growing peers. FSGS captures some of this upside because its holdings do grow faster than the broader market. However, the quality filter — the insistence on reasonable debt levels, positive cash flow, and financial discipline — means that FSGS typically trails the most aggressive growth-focused small-cap funds in strong rallies. A fund with no such constraints, loading up on zero-revenue software startups or highly leveraged special-purpose acquisition companies, may deliver outsized returns when sentiment favors risk.

The real test for a fund like FSGS comes during downturns and recessions. When the economy slows and growth becomes scarcer, investors rotate away from expensive growth stories toward cheaper, safer alternatives. At that point, the quality filter that was seen as a drag in the bull market becomes a shield. FSGS holdings, because they carry less debt and have some margin of safety in their balance sheets, tend to hold up better than the most aggressive growth peers. A leveraged small-cap growth fund that crashed 50% in the last recession may recover to the upside eventually, but FSGS may only fall 30% or so, because its companies have the financial flexibility to survive the downturn without distress. Over a full market cycle, this “quality tax” during booms is offset by the downside protection during busts.

The fund typically holds 130 to 180 securities, giving it meaningful diversification without so much breadth that the growth mandate is diluted. The portfolio skews toward industrials with pricing power, healthcare services with growing demand, business software, and specialized financial services firms. It deliberately avoids highly capital-intensive sectors like semiconductors or airlines, where growth is hard-won against cyclical pressures. The trading volume is usually adequate for most investors, with the fund trading several million shares daily and holding several billion in assets.

Expense ratios for FSGS are typically in the 0.65% to 0.80% range, reflecting the ongoing work of screening for both growth and quality. This is higher than a passive small-cap fund, but justified if the screens actually add value by identifying companies with better risk-adjusted returns. Whether FSGS outperforms over time depends on whether growth companies with solid balance sheets actually do outperform highly leveraged growth stocks on a risk-adjusted basis — a question that hinges on market conditions and management execution.

For investors, the key challenge is understanding what “growth” means in the small and mid-cap context. Revenue growth alone is not sufficient; many unprofitable companies post spectacular revenue growth before collapsing. Earnings growth, the more rigorous metric, requires that the company not only sells more but also converts those sales into profit. FSGS emphasizes companies that show evidence of earnings expansion alongside a fortress balance sheet. This screens out the speculative end of the growth spectrum but captures genuine quality growers — businesses that are scaling and should become larger, more stable companies if execution goes well.

Research into FSGS should involve reviewing the fund’s holdings and understanding which specific business models are being captured. A software company with 20% annual revenue growth, positive operating cash flow, and net margins of 5% is a very different proposition than a biotech firm burning cash on R&D with hopes of a blockbuster approval. Both might show “growth,” but the fund’s quality filter should bias heavily toward the former. Examining the fund’s track record across full market cycles — including at least one significant correction or recession — reveals how well the growth-and-quality combination has worked in practice. Comparing FSGS to competitors from other sponsors shows whether the same quality-growth thesis is being executed better or worse than alternatives.